# Sarcopenia and Paclitaxel-Induced Neuropathy in Early Stage Breast Cancer (Neuro-Sarc)

> **NCT06996548** · — · COMPLETED · sponsor: **Gazi University** · enrollment: 120 (actual)

## Conditions studied

- Sarcopenia
- Paclitaxel Induced Neuropathy
- Breast Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06996548
- **Lead sponsor:** Gazi University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-05-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06996548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06996548, "Sarcopenia and Paclitaxel-Induced Neuropathy in Early Stage Breast Cancer (Neuro-Sarc)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06996548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*